🔗 Share this article

The prestigious award in medical science has been awarded for revolutionary findings that clarify how the body's defense network attacks harmful infections while sparing the healthy tissues.

A trio of esteemed researchers—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—received this honor.

The research uncovered specialized "sentinels" within the defense system that remove rogue defense cells that could attacking the organism.

The discoveries are now paving the way for innovative treatments for immune disorders and malignancies.

These winners will share a prize fund valued at 11m Swedish kronor.

Crucial Findings

"The work has been essential for understanding how the body's defenses functions and why we do not all develop severe autoimmune diseases," commented the head of the award panel.

This trio's research address a fundamental mystery: In what way does the defense system defend us from countless infections while leaving our own tissues intact?

The immune system uses white blood cells that search for indicators of infection, even viruses and bacteria it has never encountered.

These cells utilize detectors—called receptors—that are produced by chance in countless variations.

This gives the immune system the capacity to fight a wide array of threats, but the unpredictability of the mechanism inevitably produces immune cells that can attack the host.

Security Guards of the Immune System

Researchers previously understood that a portion of these problematic white blood cells were destroyed in the immune organ—where white blood cells develop.

The latest Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the system to disarm any defenders that assault the body's own tissues.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel added, "The findings have laid the foundation for a novel area of investigation and spurred the creation of new treatments, for instance for tumors and autoimmune diseases."

In cancer, regulatory T-cells prevent the system from fighting the tumor, so studies are focused on reducing their numbers.

For self-attack disorders, experiments are exploring boosting regulatory T-cells so the organism is not under attack. A comparable approach could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Studies

Prof Sakaguchi, of Osaka University, performed tests on mice that had their immune gland extracted, leading to self-attack conditions.

He demonstrated that injecting immune cells from other animals could prevent the disease—suggesting there was a system for preventing immune cells from attacking the host.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in mice and humans that resulted in the discovery of a genetic factor vital for how T-regs function.

"Their pioneering work has uncovered how the body's defenses is controlled by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," commented a leading biological science specialist.

"This research is a remarkable example of how basic biological research can have far-reaching implications for human health."